These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31146619)

  • 1. Pharmaceutical Formulation Methods for Improving Retinal Drug Delivery.
    Stryjewski TP; Stefater JA; Eliott D
    Semin Ophthalmol; 2019; 34(4):218-222. PubMed ID: 31146619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in liposomal drug delivery systems for the treatment of retinal diseases.
    Urquhart AJ; Eriksen AZ
    Drug Discov Today; 2019 Aug; 24(8):1660-1668. PubMed ID: 30958994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spray congealing: a versatile technology for advanced drug-delivery systems.
    Bertoni S; Dolci LS; Albertini B; Passerini N
    Ther Deliv; 2018 Nov; 9(11):833-845. PubMed ID: 30444462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanosizing--oral formulation development and biopharmaceutical evaluation.
    Kesisoglou F; Panmai S; Wu Y
    Adv Drug Deliv Rev; 2007 Jul; 59(7):631-44. PubMed ID: 17601629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation strategy and use of excipients in pulmonary drug delivery.
    Pilcer G; Amighi K
    Int J Pharm; 2010 Jun; 392(1-2):1-19. PubMed ID: 20223286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects.
    Chavhan SS; Petkar KC; Sawant KK
    Crit Rev Ther Drug Carrier Syst; 2011; 28(5):447-88. PubMed ID: 22077201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-formulations of drugs: Recent developments, impact and challenges.
    Jeevanandam J; Chan YS; Danquah MK
    Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel strategies for the formulation and processing of poorly water-soluble drugs.
    Göke K; Lorenz T; Repanas A; Schneider F; Steiner D; Baumann K; Bunjes H; Dietzel A; Finke JH; Glasmacher B; Kwade A
    Eur J Pharm Biopharm; 2018 May; 126():40-56. PubMed ID: 28532676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing active pharmaceutical ingredient raw material variability during twin-screw blend feeding.
    Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Schubert MA; Vervaet C; De Beer T
    Eur J Pharm Biopharm; 2019 Feb; 135():49-60. PubMed ID: 30582959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative formulations for controlled drug delivery to the lungs and the technical and toxicological challenges to overcome(.).
    Aragao-Santiago L; Bohr A; Delaval M; Dalla-Bona AC; Gessler T; Seeger W; Beck-Broichsitter M
    Curr Pharm Des; 2016; 22(9):1147-60. PubMed ID: 26675224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanoparticles as drug/gene delivery systems to the retina.
    del Pozo-Rodríguez A; Delgado D; Gascón AR; Solinís MÁ
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):173-88. PubMed ID: 23286300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal drug delivery in retinal disease: are we out of our depth?
    Thakur SS; Barnett NL; Donaldson MJ; Parekh HS
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1575-90. PubMed ID: 24931577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches to retinal drug delivery.
    Janoria KG; Gunda S; Boddu SH; Mitra AK
    Expert Opin Drug Deliv; 2007 Jul; 4(4):371-88. PubMed ID: 17683251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular pharmacology in the treatment of vitreous, retina and choroid diseases].
    Filho PA; Maia M; Rodrigues EB; Farah ME
    Arq Bras Oftalmol; 2010; 73(3):294-9. PubMed ID: 20730292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug stability testing and formulation strategies.
    Wu Z
    Pharm Dev Technol; 2018 Dec; 23(10):941. PubMed ID: 31284808
    [No Abstract]   [Full Text] [Related]  

  • 19. BCS class IV drugs: Highly notorious candidates for formulation development.
    Ghadi R; Dand N
    J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
    Muankaew C; Loftsson T
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.